Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia

NCT02872818 is registered in ClinicalTrials.gov with Kayseri Education and Research Hospital as lead sponsor.

NCT NCT02872818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02872818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia
Lead sponsor
Kayseri Education and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2014
Completion date
March 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apoptotic signal pathways in endometrial hyperplasia